JAZZ
Common StockJazz Pharmaceuticals plc
Reported Shares
167.8K
Position Mix
No options reported
Reported Value
$38.9M
Portfolio Weight
14.64%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$265.4M
Data Refreshed
Nov 18, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
JAZZ
Common StockJazz Pharmaceuticals plc
Reported Shares
167.8K
Position Mix
No options reported
Reported Value
$38.9M
Portfolio Weight
14.64%
ENTA
Common StockENANTA PHARMACEUTICALS INC
Reported Shares
2.9M
Position Mix
No options reported
Reported Value
$37.8M
Portfolio Weight
14.23%
UTHR
Common StockUNITED THERAPEUTICS Corp
Reported Shares
66.3K
Position Mix
No options reported
Reported Value
$35.9M
Portfolio Weight
13.53%
BMRN
Common StockBIOMARIN PHARMACEUTICAL INC
Reported Shares
524.8K
Position Mix
No options reported
Reported Value
$31.5M
Portfolio Weight
11.86%
ABT
Common StockABBOTT LABORATORIES
Reported Shares
200K
Position Mix
No options reported
Reported Value
$19.8M
Portfolio Weight
7.45%
EXEL
Common StockEXELIXIS, INC.
Reported Shares
299.4K
Position Mix
No options reported
Reported Value
$17.5M
Portfolio Weight
6.59%
RARE
Common StockUltragenyx Pharmaceutical Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$17.1M
Portfolio Weight
6.46%
SUPN
Common StockSUPERNUS PHARMACEUTICALS, INC.
Reported Shares
350.7K
Position Mix
No options reported
Reported Value
$15.1M
Portfolio Weight
5.69%
SNY
Depositary ReceiptSanofi
Reported Shares
333.9K
Position Mix
No options reported
Reported Value
$13.8M
Portfolio Weight
5.19%
EMBC
Common StockEmbecta Corp.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$6.4M
Portfolio Weight
2.42%
ARDX
Common StockARDELYX, INC.
Reported Shares
1.8M
Position Mix
No options reported
Reported Value
$6.2M
Portfolio Weight
2.34%
BNTX
Depositary ReceiptBioNTech SE
Reported Shares
59.5K
Position Mix
No options reported
Reported Value
$5.9M
Portfolio Weight
2.20%
VNDA
Common StockVanda Pharmaceuticals Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$5.8M
Portfolio Weight
2.18%
GSK
Depositary ReceiptGSK plc
Reported Shares
96.7K
Position Mix
No options reported
Reported Value
$4.7M
Portfolio Weight
1.76%
BIIB
Common StockBIOGEN INC.
Reported Shares
20K
Position Mix
No options reported
Reported Value
$4.5M
Portfolio Weight
1.70%
INMD
Common StockInMode Ltd.
Reported Shares
120.9K
Position Mix
No options reported
Reported Value
$1.7M
Portfolio Weight
0.65%
ANIP
Common StockANI PHARMACEUTICALS INC
Reported Shares
13K
Position Mix
No options reported
Reported Value
$944.0K
Portfolio Weight
0.36%
ACAD
Common StockACADIA PHARMACEUTICALS INC
Reported Shares
40K
Position Mix
No options reported
Reported Value
$806.0K
Portfolio Weight
0.30%
ZTS
Common StockZoetis Inc.
Reported Shares
10K
Position Mix
No options reported
Reported Value
$698.0K
Portfolio Weight
0.26%
EOLS
Common StockEvolus, Inc.
Reported Shares
58K
Position Mix
No options reported
Reported Value
$464.0K
Portfolio Weight
0.17%